California Life Sciences is amplifying the innovative work being done by our member companies.

Member Bulletin Board

Members can submit their articles, whitepapers, blogs or announcements creating content building blocks for the broader life science ecosystem.

Insights on R&D Capitalization

By California Life Sciences Member: Withum

Lenny Smith, Team Leader of Withum’s Life Science Tax Services discusses R&D Capitalization. Companies are now required to capitalize the costs of research and development (including software development) and amortize them between five and fifteen years. Lenny provides examples of how Withum can help via R&D credits and other tax planning opportunities. Contact Lenny Smith with any questions. See video here!

Cybersecurity Awareness & Response, Lunch & Learn

By California Life Sciences Member: ICE Consulting, Inc.

Cyber Pandemic impact on Life Science industry (10 min) Cybersecurity challenges under current business and political environment (15 min) Solutions of addressing cybersecurity challenges (20 min) Q&A (15 minutes) All attendees will receive a $25 Amazon Gift Card. Read more….

Cellipont Announces Additions to Senior Leadership Team

By California Life Sciences Member: Cellipont

Poway, CA, March 15, 2022 — Cellipont Bioservices, a contract development and manufacturing organization (CDMO) with more than 15 years of experience in manufacturing cell therapies, today announced the addition of several experienced cell therapy executives to its leadership team. Read more….

ARE, Announces Long-Term Lease With Bristol Myers Squibb for a New 427,000 RSF Innovative Research Hub in the San Diego Cluster Market

By California Life Sciences Member: Alexandria

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an urban office REIT and the first, longest-tenured and pioneering owner, operator and developer uniquely focused on collaborative life science, agtech and technology campuses in AAA innovation cluster locations, today announced that Bristol Myers Squibb (BMS) has executed a long-term lease for the development of the global biopharmaceutical company’s newest core R&D facility, an iconic 427,000 RSF world-class building at Alexandria Point. Located in the heart of the University Town Center (UTC) submarket in San Diego, Alexandria Point is the company’s first leading-edge, highly sustainable amenity-rich mega campus. Read more…

View All Articles

Submit Your Content